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Abstract
The 59untranslated regions (UTR) of the full length mRNA of the HIV-1 proviral clones pNL4.3 and pLAI, harbor an internal
ribosomal entry site (IRES). In this study we extend this finding by demonstrating that the mRNA 59UTRs of natural variants
of HIV-1 also exhibit IRES-activity. Cap-independent translational activity was demonstrated using bicistronic mRNAs in HeLa
cells and in Xenopus laevis oocytes. The possibility that expression of the downstream cistron in these constructs was due to
alternative splicing or to cryptic promoter activity was ruled out. The HIV-1 variants exhibited significant 59UTR nucleotide
diversity with respect to the control sequence recovered from pNL4.3. Interestingly, translational activity from the 59UTR of
some of the HIV-1 variants was enhanced relative to that observed for the 59UTR of pNL4.3. In an attempt to explain these
findings we probed the secondary structure of the variant HIV-1 59UTRs using enzymatic and chemical approaches. Yet
subsequent structural analyses did not reveal significant variations when compared to the pNL4.3-59UTR. Thus, the
increased IRES-activity observed for some of the HIV-1 variants cannot be ascribed to a specific structural modification. A
model to explain these findings is proposed.
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Introduction
Initiation of protein synthesis in the eukaryotic cell is a complex
process that leads to the assembly of the 80S ribosome at the start
codon of the mRNA [1,2,3]. In eukaryotic cells two mechanisms
for recruiting and positioning ribosomes on the mRNA have
evolved [1,2,3]. The primary mechanism involves the recognition
of the 59 cap structure (m
7GpppN, where N is any nucleotide) on
the mRNAs by eukaryotic translation initiation factors (eIFs) that
deliver the 40S ribosomal subunit. Upon recruitment to the
mRNA, the 40S ribosomal subunit scans downstream along the 59
untranslated region (UTR) until the initiation codon is encoun-
tered. Alternatively, an RNA structure termed the internal
ribosome entry site (IRES) can drive 40S ribosomal subunit
recruitment and positioning on the mRNA either at or upstream
of the start codon [2,4,5].
The 59 UTR of the full length or genomic RNA of the human
immunodeficiency virus type-1 (HIV-1), prototype member of
the lentivirus genus of the Retroviridae and the etiologic agent of
AIDS, plays key roles during the viral life cycle [6]. The study of
the mechanism of translation exhibited by HIV-1 genomic RNA
revealed that the synthesis of the viral structural protein Gag can
be initiated both through the canonical cap-dependent mecha-
nism [7,8,9], or by the alternative IRES-dependent mechanism
[9,10,11,12,13,14]. The capped and polyadenylated HIV-1
genomic RNA has been described to harbor two IRESes, the
first within the mRNA’s 59UTR (here referred to as the HIV-1
IRES) [10,14], and the second within the Gag open reading
frame (referred to here as the HIV-1 gag IRES) [11,12,15]. The
observed conservation of both cap- and IRES-dependent
mechanisms of translation initiation among primate lentiviruses,
coupled with the redundancy this provides, suggests that
initiation of proteins synthesis is a key process during the viral
life cycle [9,12,13,16].
Since its first characterization [10] a number of additional
reports have addressed various aspects concerning the HIV-1
IRES [9,13,14,17,18,19,20]. One recognized caveat, however, of
these and other reports concerning the mechanism of HIV-1
translation initiation is that findings are based upon the study of
the 59UTR sequence recovered from only two infectious clones
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existence and relevance of IRES activity in the context of
natural HIV-1 variants remains a matter of controversy and
debate [7,16]. In this study we demonstrate that the 59UTRs of
viral RNAs isolated from HIV-1 infected individuals show a
capability to drive cap-independent translation initiation similar
to that observed for the 59UTRs of clones pNL4.3 and pLAI
[10,14,18,19].
Results
The HIV-1 59UTR Isolated from Natural Viral Variants
Drives Translation when in the Context of a Bicistronic
mRNA
At present, IRESes are defined solely by functional criteria
[21,22]. The presence or absence of IRES activity within mRNAs
of natural HIV-1 variants (VAR) was therefore evaluated using a
bicistronic mRNA approach similar to that described by Brasey et
al. (2003) and Gendron et al. (2011). To generate bicistronic VAR
vectors (Fig. 1A), natural variant 59UTR sequences (nucleotides 1-
336 with respect to HIV-1 clone pNL4.3; AF 324493) were
recovered from randomly pooled viral RNA extracts and cloned
into a dual luciferase (dl) reporter construct containing an
upstream Renilla luciferase gene (RLuc) and a downstream firefly
luciferase gene (FLuc) [10]. All plasmids were sequenced
(Macrogen Corp, Rockville, MD, USA). Variant HIV-1 59UTR
sequences were aligned against the 59UTR of pNL4.3, used in this
study as the reference IRES [10]. Thirteen dl VAR vectors
arbitrarily numbered dl VAR 1 to dl VAR 13 were randomly
selected to continue the study. The sequence differences between
the VAR 59 UTRs and pNL4.3 are highlighted in Table 1. As an
additional control we also constructed the bicistronic vector dl
HXB2 that features the 59UTR of the HIV-1 clone HXB2
(recovered from bicistronic constructs described in [11]), the
laboratory adapted version of HIV-LAI, in the intercistronic space
(Fig. 1A). Plasmids (200 ng) were then transfected into HeLa cells
using the JetPei system (Polyplus-transfection SA, Illkirch, France)
following well established protocols [23]. After 24 h total proteins
were recovered and the FLuc and RLuc activities were measured
as described in material and methods. In common with previous
studies [10,18,19,23,24], the FLuc/RLuc ratio was used as the
readout of IRES activity expressed as relative translation activity
(RTA), with the mean translation efficiency of the reference IRES
(pNL4.3, dl HIV-1 IRES vector) arbitrarily set at 100% (+/-
standard deviation). The dl DEMCV vector containing the
?EMCV sequence in the intercistronic space was used as a
negative control (Fig. 1A) [10,25]. In agreement with the report of
Gendron et al. (2011) the 59UTR of the HXB2 infectious clone of
HIV-1 exhibited IRES activity (Fig. 1B), confirming that cap-
independent translation initiation is not restricted to the 59UTR of
the HIV-1 clone pNL4.3. Additionally, figure 1B shows that when
in the context of a bicistronic mRNA all VAR 59UTRs are
capable of driving protein synthesis. However, translational
activity of VAR-IRESes varied considerably, from approximately
50% to up to 400% RTA (Fig. 1B). The residual activity of the dl
DEMCV RNA, lacking an IRES altogether, is 1% relative to the
control dl HIV-1 IRES (not subtracted from the values presented
in figure 1B). Collectively, these observations are in concordance
with reported cap-independent translational activity by 59UTR
sequences of other members of the Retroviridae and some
retroelements [10,14,23,26,27,28,29,30,31,32,33,34,35,36,37],
and strongly support the notion that the 59UTRs of all natural
variants of HIV-1 recovered from clinical samples harbor active
IRES elements. Additionally, the observed variability in RTA and,
by inference IRES activities is difficult to ascribe to anything other
than to 59UTR sequence variability between clones (Table 1).
Interestingly, yet in agreement with previous reports, careful
comparative analysis of the variant sequences described herein
reveals that translational activity from the HIV-1 IRES is
remarkably forgiving of the introduction of mutations within its
primary sequence [14,20].
Figure 1. Translational activity of the natural HIV-1 59UTR
variants isolated from clinical samples. (A) Schematic representa-
tion of the bicistronic vectors (mRNAs) used in this study. Vectors dl
DEMCV and dl HIV-1 IRES have been previously described [10,25]. The
HIV-1 59UTRs recovered from the HXB2 infectious clone or from RNA
isolated from clinical samples were cloned into dual luciferase
bicistronic (dl) vectors harboring Renilla (RLuc) and Firefly (FLuc)
luciferases as reporter genes to generate the dl VAR and dl HXB2
vectors. The dl VAR vectors were arbitrarily numbered 1-13. The 59UTR
recovered from the HIV-1 infectious clone pNL4.3, dl HIV-1 IRES, was
used as the reference IRES [10], while the RLuc/FLuc bicistronic vector
harboring a defective encephalomyocarditis virus (DEMCV) IRES, dl
DEMCV, was used as a negative control [10,25]. (B) Bicistronic vectors
were transfected into HeLa cells, which were processed 24 h thereafter.
RLuc and FLuc activities were measured and the [(FLuc/RLuc)] ratio was
used as an index of IRES activity, with the [(FLuc/RLuc)] ratio of the dl
HIV-1 IRES arbitrarily defined as 100%. Values are the means +/- SEM
from three independent experiments.
doi:10.1371/journal.pone.0035031.g001
HIV-1 IRES
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Bicistronic mRNAs
Studies to identify internal initiation in isolated viral or cellular
RNA regions utilizing the transfection of bicistronic reporter
plasmids as described above have seen strong criticism [38,39]; a
commonly cited caveat to the experimental approach being false-
positive IRES activity attributable to alternative splicing or cryptic
promoter activity [38,39]. In view of the sequence disparity
between the natural variants and the reference pNL4.3-IRES [10],
we undertook to verify the presence of the full length bicistronic
RNA in cells transfected with the dl VAR plasmids (Table 1). VAR
IRESes that exhibited activity similar to or below the reference
pNL4.3-IRES, were not included in this analysis. Total RNA was
extracted from cells previously transfected with dl VAR1, dl
VAR2, dl VAR3, dl VAR4, or dl VAR12, and analyzed by RT-
PCR as described by us and others (Fig. 2A) [23,40,41,42]. Our
results indeed confirmed the presence of full length bicistronic
mRNA for the dl DEMCV, the dl HIV-1 IRES, and all tested dl
VAR constructs (Fig. 2B). Even though results are not quantitative
nor do they rule out the presence of other RNA species, they
confirm, in all cases, the expression of the full-length bicistronic
mRNA (Fig. 2B). No product was observed when the PCR
reaction was conducted without a previous step of reverse
transcription confirming the absence of DNA contamination in
the RNA preparation (Fig. 2B). Next we quantified the amount of
bicistronic mRNA by individually amplifying RLuc or FLuc using
a quantitative RT-qPCR assay (Fig. 2C). For this total RNA
extracted from cells transfected with dl DEMCV, dl HIV-1 IRES,
dl VAR1, dl VAR2, dl VAR3, dl VAR4, or dl VAR12, was
amplified in parallel reactions using primers specifically designed
to recognize RLuc or FLuc (Fig. 2C). The RNA concentration
(pmol) obtained by quantifying the FLuc cistron was divided by
the RNA concentration (pmol) obtained by quantifying RLuc
cistron (Fig. 2D). Results show that for the different RNAs the
RNA-FLuc/RNA-RLuc ratio was close to one; dl DEMCV (1.0),
dl HIV-1 IRES (0.97), dl VAR1 (1.2), dl VAR2 (1.1), dl VAR3
(1.0), dl VAR4 (0.75), or dl VAR12 (1.2) (Fig. 2D). One exception
could however be VAR4 as the results revealed a slight, yet not
significant, increase in bicistronic RNA when RLuc cistron was
quantified (RNA-FLuc/RNA-RLuc ratio equal to 0.75). In despite
of this observation, in general and when taking together, results
presented in figures 2B and 2D suggest that only one RNA species
expressing RLuc and FLuc is generated.
Next we evaluated if this bicistronic mRNA could indeed drive
cap- and IRES dependent translation initiation. After several
unsuccessful results using RNA transfection assays in cells, we
decided to address this question in Xenopus laevis oocytes, an
experimental system that has proven useful for the study of viral
IRESes [19,20,23,43,44]. In vitro synthesized, capped and
polyadenylated RNAs corresponding to the dl DEMCV, dl
HIV-1 IRES, and the dl VAR vectors were microinjected into
the cytoplasm of Xenopus laevis oocytes (Fig. 3A). RLuc and FLuc
activities were measured 24 h post-injection (Fig.3A) as standard-
ized in previous studies [19,20,23]. All values were expressed
relative to the RLuc or FLuc activity obtained with the control dl
HIV-1 IRES RNA [10], which was arbitrarily set to 1 (Fig. 3B).
The RLuc levels from the dl HIV-1 IRES, and the dl VAR
mRNAs were comparable, suggesting not only that cap-dependent
translation initiation was functional in oocytes, but also confirming
that similar amounts of RNA were microinjected in all cases
(Fig. 3B). As described in previous studies [19,20,23], a low level of
expression from the second cistron of the dl DEMCV reporter
RNA, considered to be background, was also observed (Fig. 3B).
FLuc from all the tested dl VAR RNAs was expressed well in
excess of dl DEMCV background levels (Fig. 3.B), demonstrating
that in the context of a bicistronic RNA the VAR 59UTRs are
certainly capable of driving cap-independent translation in Xenopus
laevis oocytes. Again (see Fig.1) the translational activity of the
VAR 59UTRs was greater than that of the control pNL4.3
59UTR, while the IRES activities of the HXB2 and pNL4.3
59UTR were comparable (Fig. 3.B). Findings also suggest that
RNA splicing is not a requirement for the expression of the FLuc
Table 1.
Variant (VAR) Nucleotide changes with respect to pNL4.3 (AF 324493)
1 C23U, A46G, C95U, A133G, 149InsUAAUACU, C152G, 156DelInsAGAA, A161C, G166A, A168G, U200C, G202A, C207U, G217A, G224A, 256InsA, G257A,
A263G, 301DelAA, A305U
2 C23U, A46G, C95U, A133G, 149InsUAAUACU, C152G, 156InsAGAA, A161C, G166A, C207U, G217A, G224A, 256InsA, A263G, G279A, A286G, 301DelAA,
A305U
3 C23U, A46G, A47G, U86C, C95U, A133G, 149InsUAAUACU, C152G, 156DelInsAGAA, A161C, G166A, C207U, G217A, G224A, 256InsA, G257A, A263G,
G279A, 301DelAA, A305U
4 A46G, C95U, A96C, A161C, A215G, G217A, G224A, A227C, C233U, G265A, C300U, A301G, A305U
5 A302U, A303C, A304C, A305U
6 U100C
7 C316U
8 A314G
9 U155C, A209G, G283A, 286DelA
10 A73G, U155C, A209G, G283A, 286DelA
11 A34G, G148C, A302U, A303C, A304C, A305U, G318A
12 G11A, C23U, U24A, A47G, C95U, A96C, C152A, U155G, 156InsU, A161C, 165DelU, G167A, U201C, A214U, 217DelG, A227C, C258U, 302DelAA, A304U
13 C23U, A47G, C95U, A96C, C152A, U153C, U155G, 156InsU, A161C, 165DelU, G167A, U201C, A214U, 217DelG, A227C, C258U, A301G, 303InsAAAAU,
A304U
HXB2 C95U, A96C, U213G, A214G, G217A, A227C
Del: Deletion; Ins: Insertion.
doi:10.1371/journal.pone.0035031.t001
HIV-1 IRES
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35031reporter in Xenopus laevis oocytes. As an additional control dl
DEMCV, dl HIV-1 IRES, and dl VAR DNA plasmids were
microinjected into the cytoplasm of Xenopus laevis oocytes. In all
cases neither RLuc nor FLuc activity could be detected,
eliminating the possibility of de novo RNA synthesis from a DNA
template (data not shown). Together, these data provide
substantial evidence supporting the presence of IRESes within
the VAR 59UTRs examined. Furthermore, our observations are in
Figure 2. The full length bicistronic RNA is expressed from the dl VAR vectors. (A) Schematic representation of the experimental procedure
to detect the full length bicistronic mRNA showing the primers and the size of the expected amplicons [23]. (B and D) HeLa cells were transfected
with 200 ng of the dl HIV-1, dl DEMCV, or the different dl VAR plasmids. Total RNA was extracted from transfected cells and quantified. (B) Extracted
RNA (3 mg) was used as template in a one-step RT-PCR designed to specifically detect the bicistronic RNAs (lanes 4, 6, 8, 10, 14, and 16). To assay for
DNA contamination the same reaction was conducted in the absence of reverse transcriptase (lanes 5, 7, 9, 11, 13, 15, 17). In vitro transcribed dl HIV-1
IRES RNAs (lane 2) and water (lane 3) were included as RT-PCR controls. (C) Schematic representation of the experimental procedure to detect the
RLuc-RNA and FLuc-RNA showing the primers and the size of the expected amplicons (D) Total RNA (200 ng) extracted from transfected HeLa cells
was used as template in parallel RT-qPCR reactions designed to specifically detect the RLuc or FLuc containing RNAs. The RNA-FLuc concentration
(pmol)/RNA-RLuc (pmol) ratio was calculated. Values are the means +/- SEM from three independent experiments (each RNA sample was amplified in
three independent reactions).
doi:10.1371/journal.pone.0035031.g002
HIV-1 IRES
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viral proteins are not required to obtain a basal level of HIV-1
IRES activity in Xenopus laevis oocytes.
Expression of FLuc in the Bicistronic mRNAs is not Due to
Cryptic Promoter Activity
The firefly luciferase reporter gene has recently been shown to
exhibit a cryptic promoter activity that is detectable both in yeast
and in mammalian cells [45]. Even though the identified promoter
lies within the FLuc coding sequence and is expected to generate
shorter mRNAs that do not code for the functional luciferase
enzyme [45], we were interested in establishing if possible aberrant
transcripts may be influencing the results of the experiments
described above (Fig. 1, Fig. 2). For this, we removed the SV40
promoter from the bicistronic constructs (Fig. 4A). In this setting,
expression of the downstream transgene would imply that the
DNA coding the bicistronic mRNA possesses a cryptic promoter
activity that gives rise to at least an RNA species that engenders a
functional luciferase enzyme [38]. If so, this aberrant gene
expression would be clouding our interpretation of the data
[38]. Promoterless bicistronic vectors were transfected into HeLa
cells and cells processed 24 h later. In this experiment DNA, RNA,
and protein were recovered following previously described
protocols [23]. PCR-analysis, confirmed that all cells were
positively transfected with the dl vectors (Fig. 4B, upper panel).
RNA analysis by RT-PCR [23], confirmed the expression of the
bicistronic (RLuc-FLuc) RNA only in cells transfected with the
constructs that contained an active SV40 promoter (compare data
in Fig. 2 with Fig. 4, lower panel). Furthermore, the analysis of
RLuc and FLuc activities confirmed that the reporter proteins
were not expressed for any of the dl vectors lacking the SV40
promoter even though DNA was present in cells (Fig. 4C).
Detection of the full length bicistronic mRNA is not sufficient to
fully discard the production of shorter aberrant RNA species.
Nonetheless, the lack of luciferase activity when using the
promoterless bicistronic RNAs strongly suggests that if shorter
aberrant RNA species are formed their contribution to the overall
RLuc and FLuc activity is marginal (Fig. 4C). Results confirm that
the full length bicistronic mRNA accounts for most, if not for all,
the expression of the luciferase reporters the bicistronic constructs
(Fig. 4C).
Careful analysis of the data presented in figure 4C shows low
levels of FLuc activity (16%) in the dl VAR 12 lacking the SV40
promoter. Thus, in this particular construct dl VAR 12, we cannot
definitively exclude the presence of a cryptic promoter (Fig. 4C).
Further experiments are required to absolutely discard this
possibility. Nonetheless, and based on the same analysis we
exclude the possibility that FLuc activity from the dl VAR 1, dl
VAR 2, dl VAR 3, and dl VAR 4 constructs observed in HeLa
cells is due to the protein production from an additional transcript
encoding FLuc that was generated via a cryptic promoter.
Chemical and Enzymatic Probing of the Variant HIV-1
59UTRs
IRES activity is highly dependent on RNA structure [4,46,47].
Spurred on by the unexpected translational activity exhibited by
variantsVAR1,VAR2,VAR3andVAR4relativetothereference
pNL4.3IRESincells(293%,409%,231%and174%,respectively),
wesoughttoexploretheimpactofnucleotidevariationsdescribedin
Table 1 on the predicted secondary structure of the respective 59
UTRs. We recently reported the structure of the HIV-1 59UTR
recovered from the dl HIV IRES construct (nucleotides 1-336 from
clone pNL4.3 followed by 58 nucleotides comprising the fluc gene)
[20]. The structure was determined by probing RNA using
DiMethyl sulfate (DMS), N-Cyclohexyl-N- [N-Methylmorpho-
lino-ethyl]-Carbodiimide-4-Toluolsulfonate (CMCT) and RNAse
V1 (Fig. 5A). Using the same experimental approach we probed the
59UTRrecoveredfromvariantsdlVAR1,dlVAR2,dlVAR3and
dl VAR 4. CMCT and DMS were used to detect accessible RNA
functionalgroupsconsistingofsinglestrandedregions,whileRNAse
V1 revealed stacked or paired nucleotides. Modifications were
mapped by reverse transcription using a
32P-labeled primer. For
eachrunthereversetranscription(RT)patternofthemodifiedRNA
was compared to the profile obtained with a non-modified RNA.
Modifications were classified into two categories according to the
relativeintensityoftheinducedstopbycomparisonwiththecontrol.
Modificationswereclassifiedas‘‘weak’’wheninducinga2-to3-fold
increaseinintensityoftheRTstop,oras‘‘highlyreactive’’forhigher
intensities. Typical results using DMS covering the full HIV-1
59leader are shown (Fig. 5B). Only the strong hits (representing
highly reactive modifications) were considered for initial secondary
structure modeling using the Mfold algorithm as previously
described [12,48]. The models obtained for all variants (Fig. 5C to
5F), were compatible with the commonly accepted secondary
structure model of the HIV-1 59UTR [6,20,49,50,51]. Most of the
sequence differences can be easily accommodated in the secondary
structure since they often lie within loops or unstructured regions
(Fig 5C to 5F). Aside from a few point mutations, the main
differences between these variants are insertions in the PBS apical
loopwhichappearmostlyunstructuredassuggestedbyourchemical
andenzymaticprobingdata(InFig.5compareC,D,E,andFtoA).
A careful analysis of the probing data reveals three regions that
consistently differ in reactivity between the natural HIV-1 variant
Figure 3. Assessment of IRES activity present within the HIV-1
VAR 59UTR in Xenopus laevis oocytes. (A) Schematic representation
of the experimental procedure. (B) Capped and polyadenylated RNA
corresponding to the dl ?EMCV [10,25], dl HIV-1 IRES [10,19,20], dl HBX2
(pLAI), or the different dl VAR 59UTR (VAR 1, VAR 2, VAR 3, VAR 4, VAR
12) vectors (6.25 ng) were microinjected (50 nl final volume) into
Xenopus laevis oocytes as previously described [19,20,23]. Oocytes were
harvested 24 hr after microinjection, processed, and Renilla luciferase
(RLuc) and Firefly luciferase (FLuc) activities were determined as
described in Materials and Methods. Data are expressed as relative
luciferase activities, the RLuc and FLuc activities of the dl HIV-1 IRES, the
control bicistronic RNA harboring the 59UTR of pNL4.3 in the
intercistronic region between RLuc and FLuc [10], was arbitrarily set
at 1. Each value is the mean +/- SEM from at least 3 oocytes.
doi:10.1371/journal.pone.0035031.g003
HIV-1 IRES
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between the poly(A) and the PBS structure consistently shows a
different pattern in the variants compared to the pNL4.3 59UTR,
this is well exemplified by U117 and U118. Second, nucleotides A225
andG226,located39fromthePBSinthepNL4.3sequence,whichin
the variants HIV-1 59UTR are consistently two A that are strongly
reactive to DMS. Finally, the triplet A271G272A273 bulging out the
DIS hairpin are strongly hit in the variants HIV-1 59UTR although
they were not in the pNL4.3 59UTR. It should be noted however
that in a previous ‘‘SHAPE’’ study we found this triplet to be very
reactive to the single strand probe 1M7 [20] .
The Heterogeneous Nuclear Ribonucleoprotein A1
Stimulates HIV-1 IRES Activity
Several events in HIV-1 replication are orchestrated by a
diversity of viral and host proteins that interact with each other
and with the viral RNA to form HIV-1 ribonucleoprotein (RNP)
complexes [52,53]. Interestingly, these RNP complexes originate
in the nucleus and persist in the cytoplasm [52,53]. Recent studies
suggest that the heterogeneous nuclear ribonucleoprotein A1
(hnRNPA1), a protein known to associate with the viral RNA in
the nucleus as part of the HIV-1 RNP, plays a role as a positive
modulator of HIV-1 IRES activity [18]. Monette et al. (2009)
show that hnRNPA1 knockdown reduced HIV-1 IRES activity
Figure 4. Analysis of a promoterless bicistronic construct containing the HIV-1 59UTR sequences recovered from clinical samples.
(A) Schematic representation of the bicistronic constructs. The SV40 promoter from dl DEMCV (lane 4), dl HIV-1 IRES, or dl VAR was removed to
generate the equivalent promoterless (DSV40) vectors. (B) HeLa cells were transfected with DNA (200 ng) corresponding to the vectors depicted in
(A) as previously described [23]. Total DNA was extracted from transfected cells and the presence of the transfected plasmids was confirmed by PCR
(upper panel). The dl HIV-1 IRES plasmid (100 ng) was used as an amplification control. Total RNA was extracted from transfected cells and the
presence of transcripts for the DSV40-dl DEMCV, DSV40-dl HIV-1 IRES, or the DSV40-dl VAR plasmids was evaluated by a one step RT-PCR designed to
detect the bicistronic RNA (depicted in Fig. 2B) [23]. In vitro transcribed RNA (100 ng) generated from plasmids dl HIV-1 IRES (lane 2) were used as
amplification controls. (C) HeLa cells were transfected with either the 200 ng of SV40 or DSV40 version of dl DEMCV, dl HIV-1 IRES, or the different dl
VAR plasmids as previously described [23]. Cells were processed and RLuc and FLuc activities were measured. For each data point the [RLuc/(total
protein)] (left panel) and the [FLuc/(total protein)] (right panel) for the SV40 positive plasmids was arbitrary set to 100%. Values are the means +/- SD
from three independent experiments.
doi:10.1371/journal.pone.0035031.g004
HIV-1 IRES
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35031Figure 5. Secondary structure model of the 59UTR of selected HIV-1 VAR sequences. The HIV-1 59leader recovered from the dl VAR
constructs (followed by 58 nucleotides of fLuc gene) was probed using Dimethyl Sulfate (DMS), N-Cyclohexyl-N0- [N-Methylmorpholino)-ethyl]-
Carbodiimide-4-Toluolsulfonate (CMCT) and RNAse V1 as previously described [20]. (A) Secondary structure model of the control (pNL4.3) HIV-1
59UTR according to DMS, CMCT and RNAse V1 structure probing [6], a key indicating the respective reactivity to the different probes is provided
(box). Data included in the figure have been extracted from reference [20]. (B) Typical examples of DMS probing. The HIV-1 59leader was probed using
(+) DMS. Reverse transcription (RT) products were separated on a 8% gel as previously described [12,20,48]. Sequencing lanes were also included.
Note that DMS induces a premature RT stop one nucleotide before the hit. Therefore the DMS induced stops migrate faster than the corresponding
sequence product [12,20,48]. The RT pattern of the modified RNA was compared to the profile obtained with an unmodified RNA. Some hits are
indicated in the figure. The asterisks on the gel denote the FLuc initiation codon (AUG). Results for VAR 1 (C), VAR 2 (D), VAR 3 (E), and VAR 4 (F) were
fitted in a model of the HIV-1 59 leader [6] as previously described [20]. Numbering in A-F is with respect to clone pNL4.3, here considered the wt
sequence. Insertions are indicated in red as independent numbers (iN, were N is the number). Nucleotide changes with respect to clone pNL4.3 are
indicated in green. The nucleotide located before a deletion is highlighted in yellow, in this case numbering with respect to pNL4.3 is not altered.
doi:10.1371/journal.pone.0035031.g005
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initiation from the HIV-1 59UTR. These experiments were
conducted using the 59UTR of pNL4.3 this prompted us to
explored the effect of hnRNPA1 overexpression on VAR-IRES
activity. To evaluate this possibility a plasmid expressing
hnRNPA1 [18], was cotransfected with each dl VAR plasmids.
In this assay the dl HIV-1 IRES vector was used as a positive
control as its response to hnRNPA1 has been documented [18].
After 24 h total proteins were recovered and the FLuc and RLuc
activities were measured. The FLuc/RLuc ratio was used as the
readout of IRES activity [10,18,19,23,24]. FLuc/RLuc ratio for
each independent dl VAR vector, when co-transfected with the
empty control vector was arbitrarily set as the base line IRES
activity (Fig. 6). Results for each vector were expressed as
percentage of stimulation (%) in respect to its base line (Fig. 6).
In agreement with the report of Monette et al. (2003), hnRNPA1
stimulated translational activity from the HIV-1 IRES (90% of
additional activity), additionally hnRNPA1 overexpression stimu-
lated translation of all the VAR 59UTRs (Fig. 6). Therefore, alike
the 59UTR of pNL4.3, all VAR-IRES are responsive to
hnRNPA1 overexpression. However, translation stimulation was
not equivalent for all VAR 59UTRs (ranging from 36% to 83%).
Strikingly, VAR 1 (36%), VAR 2 (48%) and VAR 4 (43%)
59UTRs, the IRES elements with the highest activity (Fig. 1B),
showed less responsiveness to the overexpression of hnRNPA1
(Fig. 6). Further experiments are required to elucidate the
significance of these observations. Nonetheless, results presented
in figure 6 confirm that hnRNPA1 is also an IRES transacting
factor (ITAF) for the HIV-1 VAR IRESes.
Discussion
The HIV-1 IRES was identified by cloning the 59UTR of the
laboratory adapted HIV-1 infectious recombinant proviral clone
NL4.3 (pNL4.3) into the intercistronic region of a dual luciferase
(dl) reporter construct [10]. The dl reporter construct contained
the Renilla luciferase gene (RLuc) upstream and the firefly
luciferase gene (FLuc) downstream. To ensure that the two
cistrons were independently translated, a defective encephalomyo-
carditis virus IRES (?EMCV), known to inhibit ribosome
reinitiation and read-through [10,25], was inserted upstream of
the HIV-1 59UTR [10]. In this experimental setting the
translational activity of the HIV-1 59UTR was monitored using
FLuc activity as the readout, while the RLuc reporter gene served
as an upstream translational control. This approach demonstrated
that, when in the context of a bicistronic mRNA the HIV-1
59UTR of pNL4.3 was capable of driving efficient translation
initiation [10]. Most recently [14], the presence of a competent
IRES was also reported within the 59UTR of the CXCR4 (X4)-
tropic primary isolate HIV-LAI [14]. Since the discovery of the
HIV-1 IRES element, a number of additional studies have focused
on understanding the mechanisms underlying its function
[9,17,18,19,20]. However, to date all studies regarding the HIV-
1 IRES have been limited to the 59UTR of pNL4.3 or pLAI,
raising the question as to the significance and validity of these
findings in the context of naturally circulating viral variants. Here
we provide evidence that HIV-1 59UTR sequences recovered
from clinically sourced RNA isolates do indeed harbor an IRES,
suggesting that the ability of HIV-1 mRNA to drive cap-
independent translation initiation is likely to be widespread if
not ubiquitous and is not restricted to the laboratory adapted
HIV-1 clone pNL4.3 or to the single primary HIV-1 isolate, pLAI.
The full length mRNAs of the HIV-1 clone pNL4.3 and pLAI
can initiate translation through a canonical cap-dependent
mechanism [7,8,9], or by an alternative IRES-dependent
mechanism [9,10,11,12,13,14]. In this new study the translational
activity of the 59UTR of viral RNA isolated from HIV-1 infected
individuals (VAR 59UTRs) was evaluated in the context of a
bicistronic mRNA [10,14,22]. Cap-independent translation initi-
ation from the VAR 59UTRs was demonstrated in HeLa cells and
in Xenopus laevis oocytes (Fig. 2, Fig. 3 and Fig. 4). The notion that
expression of the second cistron in the bicistronic constructs may
be the result of alternative splicing or due to cryptic promoter
activity was also ruled out (Fig. 2, Fig. 3, and 4). Together, data
suggest that the 59UTR of the HIV-1 mRNAs isolated from
clinical samples enables IRES-mediated translation initiation.
Additionally, data presented in figures 1 and 2, confirm previous
observations that active translation from the HIV-1 IRES in both
HeLa cells and in Xenopus laevis oocytes does not rely on additional
viral proteins [19,20].
The 59UTR recovered from natural viral variants exhibited
extensive sequence diversity when compared to the control
sequence (Table 1). Furthermore, translational activity from some
of the HIV-1 VAR 59UTRs was enhanced substantially when
compared to the control pNL4.3 59UTR (Fig. 1 and Fig 3) and yet
these presented a number of nucleotide variations within the PBS-
stem loop (Table 1), a structural element known to be required for
IRES-mediated translation initiation [10]. These observations
prompted us to evaluate possible structural differences between the
pNL4.3 59UTR [10], and the VAR 59UTRs recovered from
clinical samples (Fig. 5). In summary, data showed that the only
differences between the VAR 59UTRs and the pNL4.3 59UTR
lied within single stranded RNA regions (Fig 5C to 5F), being the
only exception the U5 region lying in between the poly(A) and the
PBS structure, which has been predicted to be paired with the
nucleotides surrounding the initiation codon [49,51,54]. The
enhanced translational activities exhibited by some of the VAR
59UTR could therefore be attributed to a better accessibility to the
initiation codon region. However, we could not see an increase in
reactivity in this particular region (Fig. 5). Overall, enhanced
Figure 6. The hnRNPA1 protein enhances translation from the
HIV-1 59UTR. HeLa cells were transfected with either the plasmid
expressing hnRNPA1 or the equivalent empty vector in combination
with dl HIV-1 IRES or the different dl VAR vectors. Cells were processed
and RLuc and FLuc activities were measured. The FLuc/RLuc ratio for
each individual bicistronic vector in presence of the empty vector was
arbitrary set as the base line. The increase in FLuc/RLuc ratio, which
reflects the increase of HIV-1 IRES activity, in presence of the plasmid
expressing hnRNPA1 for each individual bicistronic vector is graphed as
percentage (%) of stimulation. Values are the means +/- SEM from three
independent experiments.
doi:10.1371/journal.pone.0035031.g006
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cannot easily be ascribed to specific RNA structural differences
when compared to the control pNL4.3 59UTR. Instead it may be
that nucleotide differences impact on the ability of the RNA to
recruit protein factors required for optimal IRES activity. [20].
Considerable work has been directed toward the identification of
the protein factors participating in IRES mediated translation
initiation [4,55]. Translation driven by some viral IRESes
precludes the need for certain host eIFs (differing according to
the group of IRESes under study), yet they often require additional
host proteins, the IRES trans-acting factors (ITAFs) [4,46,55,56].
Thus, enhanced IRES activity exhibited by variant 59UTRs,
which, as shown herein share RNA secondary structure similarity
with the pNL4.3 59UTR (Fig. 5), may be due to an altered
capacity of these variant RNAs to bind specific IRES activator or
inhibitor proteins [17,18,19,20]. We sought to evaluate this
possibility by analyzing the effect of hnRNPA1 on translation
driven by the variant 59UTR. A previous study defined hnRNPA1
as an ITAF for the pNL4.3 IRES [18]. As shown in figure 6,
translation driven by all variant 59UTRs was enhanced in
presence of hnRNPA1, observation that is consistent with the
findings of Monette et al. (2009). However, responsiveness to
hnRNPA1 over expression was not equivalent for all VAR
59UTRs (Fig. 6). Further hnRNPA1-RNA interaction experiments
are required to rule out if the lack of responsiveness to hnRNPA1
overexpression is due to an altered capacity of these variant RNAs
to bind the protein. In any case results suggest that hnRNPA1 is
also an ITAF for the VAR-IRESes. It should be noted that several
other proteins, including the human embryonic-lethal abnormal
vision (ELAV)-like protein HuR, the eukaryotic translation
initiation factor 5A (eIF5A), the human Rev-interacting protein
(hRIP), and the DEAD (Asp-Glu-Ala-Asp) box polypeptide 3
(DDX3), have been identified as modulators of HIV-1 IRES
activity [17,19,20]. Furthermore, and based on the report of
Vallejos et al. (2011), the list of cellular proteins that modulate
HIV-1 IRES activity is expected to increase [20].
As for most retroviral IRES elements, the biological significance
of the HIV-1 IRES within the viral context remains obscure [16].
Furthermore, several studies using monocistronic RNAs suggest
that translation initiation from the HIV-1 mRNA is mostly cap-
dependent [7,8,9]. These studies, conducted under conditions
known to favor cap-dependent translation initiation, do not
exclude the existence of an IRES within the 59UTR [8,9,20,57].
These studies do however shed light on the mechanism of
translation initiation used by an important subpopulation of viral
mRNAs. HIV-1 mRNAs are composed of a mixture of
monomethylated capped (7-methylguanosine, 7mG-) and tri-
methylated (TMG)-capped mRNAs [58]. TMG-capped-RNAs
are known to translate poorly [59], due to the inefficient
recognition of TMG-caps by the eukaryotic initiation factor 4E
(eIF4E), the cap-binding protein [60,61,62,63]. The recognition of
the 59 cap by eIF4E is the rate-limiting step in the cap-dependent
ribosome recruitment to mRNAs [1,3,55]. Therefore, TMG-HIV-
1 RNAs are likely to exhibit inefficient cap-dependent translation
initiation, thus reducing expression of the viral structural proteins.
Yet, in sharp contrast to the above prediction, TMG-capping of
viral mRNAs increases the expression of HIV-1 structural proteins
[58]. The mechanism by which these TMG-capped viral mRNAs
recruit the translational machinery remains unevaluated, yet it is
tempting to speculate that translation initiation from the TMG-
HIV-1 RNAs is mostly IRES-dependent. This possibility would
partially justify why the HIV-1 full length mRNA requires an
IRES. An additional set of reports also advocate in favor of the
requirement of a cap-independent initiation mechanism for the
HIV-1 mRNA [64,65,66,67,68,69]. IRES-mediated translation
initiation has been proposed to allow the viral mRNA to bypass
the constraints of global cellular translation repression that
normally targets cap-dependent translation initiation [1,3,55]. In
the case of the HIV-1 mRNA, IRES-mediated initiation would
support viral protein synthesis during the G2/M phase of the cell
cycle and during osmotic stress [10,14,18]. Additionally, cap-
independent translation initiation would ensure synthesis of HIV-1
structural proteins during the late stages of the replication cycle,
when the eukaryotic initiation factor eIF4G and the poly(A)
binding protein (PABP), both required for cap-dependent
translation initiation, are targeted by the HIV-1 protease
[64,65,66,68,69]. In consequence, harboring an IRES would
allow the HIV-1 mRNA to overcome translational constrains that
specifically target cap-dependent translation initiation imposed in
part by the viral replication cycle itself.
Materials and Methods
Viral RNA Purification
Surplus total RNA, extracted using the High Pure Viral Nucleic
Acid kit (Roche Diagnostics, applied science, Mannheim,
Germany) from the serum of HIV-1 infected patients, normally
discarded upon viral load determination, was randomly pooled
and used in this study as the source of viral RNA. Pooled RNA
samples were provided by the Laboratorio de Infectologı ´a,
Facultad de Medicina, Pontificia Universidad Cato ´lica de Chile.
Plasmid Construction
The dl DEMCV and the dl HIV-1 IRES plasmids were
previously described [10,25]. For the generation of the bicistronic
vectors dl VAR, the 59UTR of natural variants were recovered
from the randomly pooled viral RNA extracts by RT-PCR using
the SuperScript
TMIII one step RT-PCR system with platinumH
Taq DNA polymerase (Invitrogen, Life Technologies Corpora-
tion, Carlsbad, California, USA) using the primers HIV1-F (59-
CACGAATTCGGTCTCTCTG-39) and HIV1-R (59-
CCATGGTCTCTCTCCTTC-39). All new sequences identified
in this study can be found in GenBank (JN642552 to JN642564).
The dl VAR vectors were generated as previously described [10],
in brief the amplicon was digested with EcoRI and NcoI (both
restriction sites added by PCR) and ligated, using a triple ligation
strategy, with the 5248 bp-EcoRI/XbaI and 1656 bp -NcoI/XbaI
fragments of the previously digested dl HIV-1 IRES [10]. To
generate plasmids without the SV40 mammalian promoter, the
bicistronic vectors were digested with StuI and MluI (Fermentas),
treated with the E. coli DNA Polymerase I Klenow fragment
(Fermentas) to generate blunt ends, and ligated using T4 DNA
ligase (Fermentas). All plasmids were confirmed by sequencing
(Macrogen Corp, Rockville, MD, USA).
Cell Culture
HeLa cells, similar to those used in previous studies [10,19,20],
kindly provided by Dr. Nahum Sonenberg (McGill University,
Montreal, Canada), were cultured in Dulbecco’s modified Eagle’s
medium (Gibco-BRL) with 50 U/mL of penicillin-streptomycin
(HyClone) and 10% fetal bovine serum (HyClone) at 37uCi na5 %
CO2 atmosphere.
DNA Transfection
Cells were seeded at 10
5cell/well in 12-well plates. DNA
transfection was performed at 60% confluency by the JetPei
system (Polyplus-transfection SA, Illkirch, France) according to the
manufacturer’s protocol. For the hnRNPA1 over expression
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(125 ng) [18], kindly provided by Dr. Andrew Mouland (Lady
Davis Institute for Medical Research-Sir Mortimer B. Davis
Jewish General Hospital, Montreal, Canada) and Benoit Chabot
(University of Sherbrooke, Sherbrooke, Canada) or the empty
vector DNA (125 ng) were transfected in cells together with the
bicistronic vectors (200 ng). After 24 hours, the culture medium
was removed and the cells were lysed with the passive lysis buffer
as described in the DLR
TM Assay System manual (Promega,
Madison, WI, USA). Luciferase activities were measured using the
DLR
TM Assay System (Promega) according to the manufacturer’s
instructions on a Sirius Single Tube Luminometer (Berthold
Detection Systems GmbH, Pforzheim, Germany).
RNA, DNA Extraction, PCR, RT-PCR and RT-qPCR
Cells were washed with phosphate-buffered saline (PBS, 137
mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4?7H2O, 1.4 mM
KH2PO4, pH 7.4) at 4uC and lysed in 100 mL of RLNa buffer
(10 mM Tris–HCl (pH 8.0), 10 mM NaCl, 3 mM MgCl2,1m M
DTT, 0.5% NP40 and 10 U/mL of RiboLock
TM RNase Inhibitor
(Fermentas) for 2 min on ice. Supernatants were mixed with 1 mL
of TRIzolH Reagent (Invitrogen) and total RNA was extracted
according to the manufacturer’s instructions. Total RNA was
resuspended in 20 mL of nuclease-free water and treated using the
DNA-free
TM kit (Applied Biosystems/Ambion, Austin, TX, USA)
according to the manufacturer’s protocol. The integrity of the
RNA obtained was confirmed by electrophoresis on 1% agarose
gels and quantified by spectrophotometry (NanoDrop Technolo-
gy). DNA was extracted from cells using the EZNA
TM kit (Omega
Bio-Tek, Inc., GA, USA) according to the manufactures protocol.
DNA concentration was determined by spectrophotometry
(NanoDrop Technology).
The PCR assay was conducted using primers p2anti (59-
TCTCTTCATAGCCTTATGCAGTTG-39) and Pforluc (59-
CATGACTTCGAAAGTTTATGATC-39), 100 ng of total
DNA and the Go TaqHGreen Master mix (Promega), according
to the manufacturer’s protocol. The RT-PCR assay was carried
out with SuperScript
TM III One-Step RT-PCR System using
PlatinumH Taq DNA polymerase (Invitrogen) according to the
manufacturer’s protocol, using 1 mg of RNA and the primers
described above.
The RT-qPCR assay was conducted using the primers RLucS
(59-AGGTGAAGTTCGTCGTCCAACATTATC-39) and RLu-
cAS (59-GAAACTTCTTGGCACCTTCAACAATAGC-39) for
RLuc amplification (193bp); or FLucS (59- ACTTC-
GAAATGTCCGTTCGG-39)andFLucAS(59-GCAACTCCGA-
TAAATAACGCG-39) for FLuc amplification (135bp), using the
BrilliantH II SYBRH Green QRT-PCR Master Mix KIT
(Stratagene, Agilent Technologies Company, Santa Clara, CA,
USA). The amplification reactions were conducted under the
following conditions: 30 min at 45uC for RT step followed by
10 min at 94uC, continued by 40 cycles of 20s at 94uC, 20s at
60uC and 30s 72uC. The melting curve was performed between
60uC and 90uC to verify the reaction specificity. For each
experiment, the amount of RNA-RLuc and RNA-FLuc for each
bicistronic RNA was determined (pmoles) based on an
individual standard curve constructed using in vitro transcribed
RNA as a template. Values were corrected considering the
amplification efficiency of each couple of primers. The RNA-
FLuc/RNA-RLuc ratio was used to compare the amount of
bicistronic RNA in each transfection assay.
In vitro Transcription
Capped RNAs were synthesized using the mMESSAGE
mMACHINE High Yield Capped RNA Transcription Kit
(Applied Biosystems/Ambion, Austin, TX, USA) and polyadenyl-
ated using the Poly(A) Tailing kit (Applied Biosystems/Ambion)
according to the manufacturer’s protocol. Uncapped RNA was
synthesized by in vitro transcription conducted in a final volume of
100 mL using T7 RNA polymerase, 5 mM DTT, 5 mM rNTP’s,
1X transcription buffer (40 mM Tris-HCl pH8.0, 25 mM MgCl2,
1 mM spermidine), 0.04 U RNase inhibitor (Applied Biosystems/
Ambion), and incubated for 120 min at 37uC. To eliminated the
DNA template, 10 mL of DNAse RQ1 (Promega) was added, and
further incubated for 20 min at 37uC. The RNA was precipitated
using 2.5 M LiCl (220uC for 30 min), centrifuged at 160006g
(30 min at 4uC), washed with 70% ethanol and resuspended in
50 mL of nuclease-free water. RNA concentrations were deter-
mined spectrophotometrically (NanoDrop Technology) and RNA
integrity was monitored by electrophoresis on denaturing agarose
gels.
Oocyte Harvesting and RNA Microinjection
Oocytes were isolated from Xenopus laevis ovarian fragments by
manual dissection as previously described [70]. Oocytes were
incubated at 15uC for 24 h in standard Barth’s solution
supplemented with 10 IU/l penicillin–streptomycin, and 2 mM
pyruvate [70]. To evaluate viral IRES activity in oocytes, 6.25 ng
of in vitro transcribed capped and polyadenylated RNA was
microinjected into each oocyte with glass micropipettes calibrated
to deliver a final volume of 50 nl [71,72]. After 24 h oocytes were
lysated in Passive Lysis buffer (Promega), centrifuged at 16,000x g
for 5 min, and 1-5 ml of the supernatant was used in the detection
assay using the DLR
TM Assay System kit (Promega).
RNA Probing
The secondary structure of the HIV-1 59UTR in vitro
transcribed RNAs (10 pMoles), which included the 59 leader of
HIV-1 (pNL4.3) and the first 58 nt of fluc open reading frame
(recovered from the dl HIV-1 IRES and dl VAR plasmids using a
primer T7HIVF 59-CCATATGTAATACGACTCACTA-
TAGGTCTCTCTGGTTAGA-39 and Fluc30bp 59-CATCTTC-
CAGCGGATAGAATG-39), was probed using DiMethyl Sulfate
(DMS, Across Organics), N-cyclohexyl-N-[N-methylmorpholino)-
ethyl]-carbodiimid-4-toluolsulfonate (CMCT, Merck) and RNAse
V1 (Applied Biosystems/Ambion) as described previously
[12,20,48]. The RNAs were resuspended in 30 mlo f8 0 m M
HEPES pH 7.5 (or 50 mM borate potassium pH 8.0 for
CMCT), denatured for 2 min at 80uC, and then 2 mLo f3 M
KCl and 2 mL of 40 mM MgCl2 were added. Following a10
min incubation at 30uC, DMS (0.2 mM final), CMCT (25 mM
final) or RNAse V1 (0.01 or 0.025 U) was added and the
mixture was incubated for 5 min (10 min for CMCT). Mock
controls, where the chemical was replaced by water, were also
included. The modification reaction was stopped on ice by
addition of 10 mg of total yeast tRNA, and precipitated on dry
ice with ethanol and 5 M ammonium. RNA was then
resuspended in 0.5 M ammonium acetate, ethanol precipitated
and resuspended in 6 mL of nuclease-free water. Modifications
were revealed by reverse transcription (AMV RT, Promega)
using
32P-labelled primer (Fluc30bp, HIV1-336R: 59-
TTTGAAAAACACGAATTCGGTCTCTCTG-39, 100pbHIV-
1: 59-ACTTTGAGCACTCAAGGCAAG-39, 200pbHIV-1: 59-
TTCGCTTTCAAGTCCCTGTTC-39) according to the manu-
facturer’s instructions (Promega). Reverse transcription products
were resolved on an 8% denaturing urea-polyacrylamide gel,
HIV-1 IRES
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Mode imager (Amersham Biosciences). The relative proportion
of each product was determined by drawing profiles using Multi
Gauge V3 software (Fujifilm).
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